C

CorMedix
D

CRMD

10.795
USD
-1.16
(-9.70%)
قبل الجلسة
حجم التداول
128
الربح لكل سهم
1
العائد الربحي
-
P/E
43
حجم السوق
803,462,847
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 10 أشهر
buy
2024-10-03 07:52
CRMD Chart
المزيد
أصول ذات صلة
A
AGEN
-0.00500
(-0.11%)
4.75000 USD
A
AKBA
-0.79500
(-20.98%)
2.99500 USD
C
CLRB
-0.07000
(-1.47%)
4.70000 USD
D
DVAX
-0.130
(-1.16%)
11.070 USD
M
MDGL
4.41
(1.31%)
342.14 USD
R
RDHL
-0.05000
(-4.03%)
1.19000 USD
R
RMTI
0.00760
(0.79%)
0.97000 USD
S
SNDX
-0.170
(-1.32%)
12.725 USD
المزيد
الأخبار المقالات

العنوان: CorMedix

القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.